Evaluation of efficacy and safety of endovascular coiling for patients with aneurysmal subarachnoid hemorrhage: A protocol for systematic review and meta-analysis
- PMID: 34011030
- PMCID: PMC8137089
- DOI: 10.1097/MD.0000000000025728
Evaluation of efficacy and safety of endovascular coiling for patients with aneurysmal subarachnoid hemorrhage: A protocol for systematic review and meta-analysis
Abstract
Background: There is an elevated risk of rebleeding when the aneurysm is left untreated in patients diagnosed with aneurysmal subarachnoid hemorrhage (SAH). Occlusion of the lumen of the aneurysm using endovascular coiling is a common method to prevent rebleeding by occluding the aneurysm. This study aims to evaluate the efficacy and safety of endovascular coiling in patients with aneurysmal SAH.
Methods: A systematic search for relevant articles will be performed in 4 English electronic databases, including MEDLINE (from 1966 to October 2020), EMBASE (from 1980 to October 2020), the Cochrane Library (from 2020, issue 10), Scopus (from 1823 to October 2020), and 3 Chinese electronic databases, including Chinese Biomedical Literature Database (from 1995 to October 2020), WanFang (last searched October 2020), and China National Knowledge Infrastructure (last searched October 2020). This study will comprise randomized controlled trials (RCTs) that evaluate the effectiveness and safety of using endovascular coiling in the treatment of aneurysmal SAH. The articles in the databases will be independently screened by 2 authors to select potential studies, extract data, and evaluate the bias risk in the selected studies. This study will use suitable statistical methods to merge result data.
Results: The results of this study will be useful in determining the efficacy and safety of endovascular coiling for treating patients with aneurysmal SAH.
Conclusion: The findings of this study will summarize the most recent evidence on the effectiveness and safety of using endovascular coiling to treat aneurysmal SAH.
Ethics and dissemination: The present work does not involve any humans or animals; therefore, ethical approval is not needed.
Systematic review registration: December 2, 2020.osf.io/yj4gq (https://osf.io/yj4gq/).
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interests to disclose.
References
-
- Connolly ES, Jr, Rabinstein AA, Carhuapoma JR, et al. . Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1711–37. - PubMed
-
- Güresir E, Vasiliadis N, Konczalla J, et al. . Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting. J Neurol Sci 2013;332:128–35. - PubMed
-
- de Oliveira Manoel AL, Turkel-Parrella D, Duggal A, et al. . Managing aneurysmal subarachnoid hemorrhage: it takes a team. Cleve Clin J Med 2015;82:177–92. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources